AI assistant
Sending…
Edgewise Therapeutics, Inc. — Director's Dealing 2021
May 4, 2021
31829_dirs_2021-05-04_3e0841a2-5b3b-45db-b06d-4603a6b4191a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-04-26
Reporting Person: Donovan Joanne M. (N/A)
More from Edgewise Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
M&A Activity
2026
Jun 1
Share Issue/Capital Change
2026
May 7
Earnings Release
2026
May 7
Interim / Quarterly Report
2026
May 7
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Mar 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Major Shareholding Notification
2026
Feb 17